Personalis vs Exagen
Personalis and Exagen are similar in size: $69.6m and $66.6m of revenue in their latest fiscal years. Exagen grew faster (19.7% against -17.7%). Exagen kept more of each dollar of sales as profit: a net margin of -30.0% against -116.7%. Personalis carries less debt relative to equity (0.0% against 131.3%).
| Latest fiscal year | PersonalisPSNL, 2025 | ExagenXGN, 2025 |
|---|---|---|
| Revenue | $69.6m | $66.6m |
| Revenue growth | -17.7% | 19.7% |
| Net income | −$81.3m | −$20.0m |
| Operating margin | -126.4% | -21.1% |
| Net margin | -116.7% | -30.0% |
| Return on equity | -35.0% | -147.8% |
| Free cash flow | −$79.5m | −$14.3m |
| Cash | $124m | $32.2m |
| Total debt | $0 | $22.9m |
| Debt to equity | 0.0% | 131.3% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 260 | 220 |
| Market value | $1.68bn | $203m |
| Price vs our value range | — | — |
| Moat score | 11 (Weak) | 16 (Weak) |
| Insider trades, 12 months | 0 buys, 16 sales | 1 buys, 5 sales |